Adagio Medical Appoints Two Seasoned Senior Executives to Accelerate Commercial Readiness 
COVID-19 Vaccination Begins at One Medical
One Medical coordinates with San Francisco Department of Public Health to offer COVID-19 vaccinations to San Francisco Phase 1a populationsSAN...
Sorrento Announces the Submission of a Marketing Authorization Application to COFEPRIS (Mexico) for COVI-STIX™ Rapid Detection Test of SARS-CoV-2 Viral Antigen
SAN DIEGO, Dec. 30, 2020 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, "Sorrento") today announced that a Marketing Authorization...
Ascendis Pharma A/S Announces Filing of Investigational New Drug Application to Initiate TransCon™ TLR7/8 Agonist Clinical Program
- TransCon TLR7/8 Agonist is designed for intratumoral, sustained release of resiquimod with minimal systemic exposure, while inducing a potent...
Adaptive Biotechnologies to Present at the 39th Annual J.P. Morgan Healthcare Conference
SEATTLE, Dec. 30, 2020 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that aims...
BioPorto announces CE mark of near-patient test for kidney injury and milestones for gRAD platform technology
December 30, 2020Announcement no. 22 BioPorto announces CE mark of near-patient test for kidney injury and milestones for gRAD platform...
Nova Leap Health Corp. to Present at the SNN Network Canada Virtual Investor Conference
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HALIFAX, Nova Scotia, Dec. 30, 2020...
Skylight Health Group Announces Closing of $13.8 Million Bought Deal Financing
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, Dec. 30, 2020 (GLOBE NEWSWIRE)...
Skylight Health Announces Closing of Tennessee Clinic with $2.2 Million in Revenue and Positive EBITDA
Company closes acquisition of Tennessee-based Perimeter Pain and Primary Care Clinic previously announced on December 3, 2020Tennessee-based Perimeter Pain and...
Sparta Capital Ltd. Announces Annual and Special Meeting Results
Not for distribution to U.S. Newswire Services or for dissemination in the United States of America. Any failure to comply...
Amarillo Biosciences, Ind. Enters into a Securities Purchase Agreement to Foster New Growth
AMARILLO, TX / ACCESSWIRE / December 30, 2020 / Amarillo Biosciences, Inc. ("we," "ABI" or the "Company"), (OTC PINK:AMAR), a...
IM Cannabis to Acquire Trichome in Landmark Transaction – Establishes Global Growth Platform and Leading Multi-Country Operator
Combined Company will be a fully-integrated global leader in adult-use recreational and medical cannabis markets and the only MCO operating...
Beta Bionics Appoints Beth Brooke to Its Board as Independent Director
CONCORD, Mass.--(BUSINESS WIRE)--Beta Bionics, Inc. — a medical technology company developing the iLet®, the world’s first fully automated bionic pancreas...
Delaying Implementation of PMPRB’s Regulations an Opportunity to Protect Patient Access to Medicines and Vaccines Says Innovative Medicines Canada
OTTAWA, ON / ACCESSWIRE / December 30, 2020 / Innovative Medicines Canada issued the following statement today in response to...
REPEAT – Pure Extracts Commences Study on Psilocybin Oral Tablets, Capsules and Nasal Gel
VANCOUVER, British Columbia, Dec. 30, 2020 (GLOBE NEWSWIRE) -- Pure Extracts Technologies Corp. (CSE: PULL) (XFRA: A2QJAJ) (“Pure Extracts” or...
VistaGen Announces Publication in CNS Spectrums Detailing Proposed Mechanism of Action of Its Investigational Neuroactive Nasal Sprays for Anxiety and Depression Disorders
Dr. Louis Monti, VistaGen’s Newly-Appointed Vice President, Translational Medicine, and Dr. Michael Liebowitz, VistaGen CNS Clinical and Regulatory Advisory Board...
Ocuphire to Present at the LifeSci Partners 10th Annual Healthcare Corporate Access Event in Early January 2021
FARMINGTON HILLS, Mich., Dec. 30, 2020 (GLOBE NEWSWIRE) -- Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company focused on developing...
BioCardia Issued New U.S. Patent for Technology that Enhances Control for Cardiac Therapies
Technology Anticipated to Impact Cardiac Biologic Therapies, Cardiac Arrhythmia, and Structural Heart ProceduresSAN CARLOS, Calif., Dec. 30, 2020 (GLOBE NEWSWIRE)...
Assure Holdings Announces Early Final Payment of Neuro-Pro Monitoring Acquisition
DENVER, Dec. 30, 2020 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (TSXV: IOM; OTCQB: ARHH), a provider...
EDAP Announces End of the Year Focal One® Sales
Among December deals closed, two major US institutions have purchased Focal OneUniversity of California, San Francisco Medical Center and Cleveland...
Morphic Therapeutic to Present at the Virtual 39th Annual J.P. Morgan Healthcare Conference
WALTHAM, Mass., Dec. 30, 2020 (GLOBE NEWSWIRE) -- Morphic Therapeutic (Nasdaq: MORF), a biotechnology company developing oral integrin therapies, today...